In vitro activity of a new pneumocandin antifungal agent, L-733,560, against azole-susceptible and -resistant Candida and Torulopsis species

J. A. Vazquez, M. Lynch, J. D. Sobel

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The activity of a new water-soluble pneumocandin, L-733,560, was evaluated with 107 pathogenic strains of Candida and Torulopsis, which included 23 strains with known multi-azole resistance patterns. In vitro evaluation of L- 733,560 activity was performed by a broth microdilution method, and the activity was compared with the activities of amphotericin B, fluconazole, ketoconazole, itraconazole, and flucytosine. The mean MICs of L-733,560 were 0.15 μg/ml for Candida albicans, 0.2 μg/ml for Torulopsis glabrata, 0.28 μg/ml for C. tropicalis, 0.36 μg/ml for C. kefyr, 0.70 μg/ml for C. lusitaniae, 0.72 μg/ml for C. parapsilosis, 0.78 μg/ml for C. krusei, and 1.25 μg/ml for C. guilliermondii. The results indicate that the new antifungal agent L-733,560 demonstrated the best activity with the lowest MICs against C. albicans, T. glabrata, C. tropicalis, and C. kefyr, less activity against C. krusei, C. lusitaniae, and C. parapsilosis, and the least activity against C. guilliermondii. L-733,560 also demonstrated good activity against the various multi-azole. resistant Candida and T. glabrata isolates.

Original languageEnglish (US)
Pages (from-to)2689-2691
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume39
Issue number12
DOIs
StatePublished - Jan 1 1995

Fingerprint

Azoles
Antifungal Agents
Candida
Candida glabrata
Candida albicans
Flucytosine
Ketoconazole
Itraconazole
Fluconazole
Amphotericin B
In Vitro Techniques
Torulopsis
Water

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

In vitro activity of a new pneumocandin antifungal agent, L-733,560, against azole-susceptible and -resistant Candida and Torulopsis species. / Vazquez, J. A.; Lynch, M.; Sobel, J. D.

In: Antimicrobial Agents and Chemotherapy, Vol. 39, No. 12, 01.01.1995, p. 2689-2691.

Research output: Contribution to journalArticle

@article{6a47d8c3a28a45079483876a222579be,
title = "In vitro activity of a new pneumocandin antifungal agent, L-733,560, against azole-susceptible and -resistant Candida and Torulopsis species",
abstract = "The activity of a new water-soluble pneumocandin, L-733,560, was evaluated with 107 pathogenic strains of Candida and Torulopsis, which included 23 strains with known multi-azole resistance patterns. In vitro evaluation of L- 733,560 activity was performed by a broth microdilution method, and the activity was compared with the activities of amphotericin B, fluconazole, ketoconazole, itraconazole, and flucytosine. The mean MICs of L-733,560 were 0.15 μg/ml for Candida albicans, 0.2 μg/ml for Torulopsis glabrata, 0.28 μg/ml for C. tropicalis, 0.36 μg/ml for C. kefyr, 0.70 μg/ml for C. lusitaniae, 0.72 μg/ml for C. parapsilosis, 0.78 μg/ml for C. krusei, and 1.25 μg/ml for C. guilliermondii. The results indicate that the new antifungal agent L-733,560 demonstrated the best activity with the lowest MICs against C. albicans, T. glabrata, C. tropicalis, and C. kefyr, less activity against C. krusei, C. lusitaniae, and C. parapsilosis, and the least activity against C. guilliermondii. L-733,560 also demonstrated good activity against the various multi-azole. resistant Candida and T. glabrata isolates.",
author = "Vazquez, {J. A.} and M. Lynch and Sobel, {J. D.}",
year = "1995",
month = "1",
day = "1",
doi = "10.1128/AAC.39.12.2689",
language = "English (US)",
volume = "39",
pages = "2689--2691",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "12",

}

TY - JOUR

T1 - In vitro activity of a new pneumocandin antifungal agent, L-733,560, against azole-susceptible and -resistant Candida and Torulopsis species

AU - Vazquez, J. A.

AU - Lynch, M.

AU - Sobel, J. D.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - The activity of a new water-soluble pneumocandin, L-733,560, was evaluated with 107 pathogenic strains of Candida and Torulopsis, which included 23 strains with known multi-azole resistance patterns. In vitro evaluation of L- 733,560 activity was performed by a broth microdilution method, and the activity was compared with the activities of amphotericin B, fluconazole, ketoconazole, itraconazole, and flucytosine. The mean MICs of L-733,560 were 0.15 μg/ml for Candida albicans, 0.2 μg/ml for Torulopsis glabrata, 0.28 μg/ml for C. tropicalis, 0.36 μg/ml for C. kefyr, 0.70 μg/ml for C. lusitaniae, 0.72 μg/ml for C. parapsilosis, 0.78 μg/ml for C. krusei, and 1.25 μg/ml for C. guilliermondii. The results indicate that the new antifungal agent L-733,560 demonstrated the best activity with the lowest MICs against C. albicans, T. glabrata, C. tropicalis, and C. kefyr, less activity against C. krusei, C. lusitaniae, and C. parapsilosis, and the least activity against C. guilliermondii. L-733,560 also demonstrated good activity against the various multi-azole. resistant Candida and T. glabrata isolates.

AB - The activity of a new water-soluble pneumocandin, L-733,560, was evaluated with 107 pathogenic strains of Candida and Torulopsis, which included 23 strains with known multi-azole resistance patterns. In vitro evaluation of L- 733,560 activity was performed by a broth microdilution method, and the activity was compared with the activities of amphotericin B, fluconazole, ketoconazole, itraconazole, and flucytosine. The mean MICs of L-733,560 were 0.15 μg/ml for Candida albicans, 0.2 μg/ml for Torulopsis glabrata, 0.28 μg/ml for C. tropicalis, 0.36 μg/ml for C. kefyr, 0.70 μg/ml for C. lusitaniae, 0.72 μg/ml for C. parapsilosis, 0.78 μg/ml for C. krusei, and 1.25 μg/ml for C. guilliermondii. The results indicate that the new antifungal agent L-733,560 demonstrated the best activity with the lowest MICs against C. albicans, T. glabrata, C. tropicalis, and C. kefyr, less activity against C. krusei, C. lusitaniae, and C. parapsilosis, and the least activity against C. guilliermondii. L-733,560 also demonstrated good activity against the various multi-azole. resistant Candida and T. glabrata isolates.

UR - http://www.scopus.com/inward/record.url?scp=0028839444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028839444&partnerID=8YFLogxK

U2 - 10.1128/AAC.39.12.2689

DO - 10.1128/AAC.39.12.2689

M3 - Article

C2 - 8593003

AN - SCOPUS:0028839444

VL - 39

SP - 2689

EP - 2691

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 12

ER -